COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00222547
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : October 28, 2005
United States Agency for International Development (USAID)
Information provided by:
University of Oxford

Brief Summary:
Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.

Condition or disease Intervention/treatment Phase
Village Children Drug: Vitamin A Drug: Albendazole Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 720000 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Deworming and Enhanced Vitamin A Supplementation DEVTA Project
Study Start Date : January 1999
Study Completion Date : February 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitamin A

Primary Outcome Measures :
  1. childhood mortality rate at age 1-6

Secondary Outcome Measures :
  1. fecal egg counts, plasma retinal, growth, sign of Vitamin A deficiency

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes


  • Area of residence

Exclusion Criteria:

  • NONE

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00222547

Layout table for location information
Shally Awasthi
Lucknow, Uttar Pradesh, India, UP226 003
Sponsors and Collaborators
University of Oxford
United States Agency for International Development (USAID)
Layout table for investigator information
Study Chair: Shally Awasthi, MD King George Medical University, Lucknow
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information Identifier: NCT00222547    
Other Study ID Numbers: DEVTA
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: October 28, 2005
Last Verified: February 2005
Additional relevant MeSH terms:
Layout table for MeSH terms
Vitamin A
Growth Substances
Physiological Effects of Drugs
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Antiparasitic Agents
Anti-Infective Agents
Anticestodal Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Tubulin Modulators
Antimitotic Agents
Mitosis Modulators